Literature DB >> 3026431

Human papillomavirus infections in a group of renal transplant recipients.

R Rüdlinger, I W Smith, M H Bunney, J A Hunter.   

Abstract

One hundred and twenty renal transplant recipients were investigated. Fifty-eight (48%) were found to have warts, 13 (11%) keratoses and six (5%) to have, or recently to have had cancers. The longer the time of immunosuppression, the greater the prevalence of warts; of those patients who had had their transplant for at least 5 years, 87% had warts. Those with a graft survival time of 10 years or more are at special risk of warts, keratoses and malignancy. Five (10%) of 50 women had genital warts, four of whom had internal lesions (vaginal, cervical or anal) and one developed a carcinoma of the vulva. These findings indicate the advisability of colposcopy for all female renal transplant recipients, a high risk group. Eighty-eight specimens from 42 patients were examined by DNA restriction enzyme analysis and cross hybridization for the presence and type of human papillomavirus (HPV). HPV DNA was detected in 66% of the warts examined, HPV2 and HPV4 occurring most often and HPV1 and HPV3 only infrequently. In sequential specimens from common hand warts of one individual, an HPV was found which could not be precisely identified but was related to HPV4. HPV16 was detected in a vaginal wart from one patient and an HPV6-related virus in a vulval wart of another. HPV DNA of an unknown type was demonstrated in one of 11 keratoses examined. With the probes used to examine the few samples of skin cancers available, HPV16 was found in a squamous cell carcinoma of the vulva, and faint bands from an unidentified type of HPV were detected in two squamous cell carcinomata from a patient's hand. One woman had plaque lesions morphologically and histologically resembling those found in epidermodysplasia verruciformis (EV). HPV5 was identified in these lesions. This is only the third reported case of HPV5, previously thought to be unique to EV, in a renal transplant recipient.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3026431     DOI: 10.1111/j.1365-2133.1986.tb06649.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  22 in total

1.  Meeting report. Report of meeting of Section of Clinical Immunology and Allergy, 11 March 1991.

Authors: 
Journal:  J R Soc Med       Date:  1992-02       Impact factor: 5.344

2.  No evidence of human papillomavirus DNA in actinic keratosis.

Authors:  S Lu; K Syrjänen; V K Havu
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 3.  Human papillomavirus and skin cancer.

Authors:  J M McGregor; M H Rustin
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

4.  Expression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regression.

Authors:  Shreya Kanodia; Diane M Da Silva; Tigran Karamanukyan; Lies Bogaert; Yang-Xin Fu; W Martin Kast
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

5.  Lymphoproliferative response to fusion proteins of human papillomaviruses in patients with cervical intraepithelial neoplasia.

Authors:  H A Cubie; M Norval; L Crawford; L Banks; T Crook
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

6.  Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine.

Authors:  Rebecca T Emeny; Cosette M Wheeler; Kathrin U Jansen; William C Hunt; Tong-Ming Fu; Judith F Smith; Stefani MacMullen; Mark T Esser; Xavier Paliard
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Analysis of CD4(+) T-cell responses to human papillomavirus (HPV) type 11 L1 in healthy adults reveals a high degree of responsiveness and cross-reactivity with other HPV types.

Authors:  O Martin Williams; Keith W Hart; Eddie C Y Wang; Colin M Gelder
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Keratin 17 expression as a marker for epithelial transformation in viral warts.

Authors:  C M Proby; L Churchill; P E Purkis; M T Glover; C J Sexton; I M Leigh
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

9.  Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer.

Authors:  Hakim Echchannaoui; Matteo Bianchi; David Baud; Martine Bobst; Jean-Christophe Stehle; Denise Nardelli-Haefliger
Journal:  Infect Immun       Date:  2008-03-10       Impact factor: 3.441

Review 10.  Cutaneous squamous cell carcinoma and human papillomavirus: is there an association?

Authors:  Bishr Aldabagh; Jorge Gil C Angeles; Adela R Cardones; Sarah T Arron
Journal:  Dermatol Surg       Date:  2012-08-28       Impact factor: 3.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.